Millipore Sigma Vibrant Logo

MABF2302-100UG Anti-HLA-A02:01 EBV-LMP2A Antibody, clone MAB243

Anti-HLA-A02:01 EBV-LMP2A, clone MAB243, Cat. No. MABF2302, is a mouse monoclonal antibody that detects EBV-LMP2A and is tested for use in ELISA, Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry, and Western Blotting.

View Products on Sigmaaldrich.com
MABF2302-100UG
100 μg  
Ricerca del prezzo in corso...
Non è stato possibile trovare il prezzo
La quantità minima deve essere un multiplo di
Maximum Quantity is
Al termine dell'ordine Maggiori informazioni
Lei ha salvato ()
 
—
Richiedi il prezzo
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

       

      Contatti il Servizio Clienti

      Panoramica

      Replacement Information
      Description
      Catalogue NumberMABF2302-100UG
      DescriptionAnti-HLA-A02:01 EBV-LMP2A Antibody, clone MAB243
      Alternate Names
      • Latent membrane protein 2
      Background InformationLatent membrane protein 2 (UniProt: P13285; also known as Terminal protein) is encoded by the LMP2 gene (Gene ID: 3783751) in Epstein-Barr virus. EBV is a gamma-herpesvirus, a causative agent of infectious mononucleosis. In healthy individuals, EBV typically establishes a persistent latent infection in which the virus can be detected in resting, nonproliferating peripheral B-lymphocytes. These latently infected cells express only 2 virally encoded genes, LMP2A and EBNA1. Although the majority of virus infected individuals remain healthy, EBV has been implicated in the pathogenesis of African Burkitt s lymphoma and nasopharyngeal carcinoma. LMP2A, a multi-pass membrane protein, localizes in plasma membrane lipid rafts. It maintains EBV latent infection of B cells by preventing lytic reactivation of the virus in response to surface immunoglobulin (sIg) cross-linking. It acts like a dominant negative inhibitor of the sIg-associated protein tyrosine kinases, LYN and SYK. It is also reported to block the translocation of the B-cell antigen receptor (BCR) into lipid rafts, which prevents the subsequent signaling and accelerated internalization of the BCR upon BCR cross-linking. It also serves as a molecular scaffold to recruit SYK, LYN and E3 protein-ubiquitin ligases leading to ubiquitination and degradation of these tyrosine kinases. LMP2A also exhibits a constitutive signaling activity in non-transformed cells, inducing bypass of normal B lymphocyte developmental checkpoints, which allows immunoglobulin-negative cells to colonize peripheral lymphoid organs. (Ref.: Lai, J., et al. (2017). Sci. Rep. 7; 9923; Rancan, C., et al. (2015). PLoS Pathol. 11(6); e1004906).
      References
      Product Information
      FormatPurified
      PresentationPurified mouse monoclonal antibody IgG1 in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ200
      Applications
      ApplicationAnti-HLA-A02:01 EBV-LMP2A, clone MAB243, Cat. No. MABF2302, is a mouse monoclonal antibody that detects EBV-LMP2A and is tested for use in ELISA, Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry, and Western Blotting.
      Key Applications
      • ELISA
      • Flow Cytometry
      • Immunocytochemistry
      • Immunofluorescence
      • Immunohistochemistry
      • Western Blotting
      Application NotesTested Applications

      ELISA Analysis: A representative lot detected HLA-A02:01 EBV-LMP2A in ELISA applications (Lai, J., et al. (2016). Blood. 128(10):1396-407; Lai, J., et al. (2017). Sci Rep. 7(1):9923).

      Immunohistochemistry Applications: A representative lot detected HLA-A02:01 EBV-LMP2A in Immunohistochemistry applications (Lai, J., et al. (2016). Blood. 128(10):1396-407).

      Western Blotting Analysis: A representative lot detected HLA-A02:01 EBV-LMP2A in Western Blotting applications (Lai, J., et al. (2016). Blood. 128(10):1396-407).

      Flow Cytometry Analysis: A representative lot detected HLA-A02:01 EBV-LMP2A in Flow Cytometry applications (Lai, J., et al. (2016). Blood.;128(10):1396-407; Lai, J., et al. (2017). Sci Rep.;7(1):9923).

      Immunofluorescence Analysis: A representative lot detected HLA-A02:01 EBV-LMP2A in Immunofluorescence applications (Lai, J., et al. (2016). Blood. 128(10):1396-407).

      Immunocytochemistry Analysis: A representative lot detected HLA-A02:01 EBV-LMP2A in Immunocytochemistry applications (Lai, J., et al. (2016). Blood. 128(10):1396-407).

      Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
      Biological Information
      ImmunogenHLA-A201 with EBV (strain B95-8) LMP2A (CLGGLLTMV) 426-434 recombinant protein.
      EpitopeC-terminal
      CloneMAB243 (also referenced as L2)
      Concentration0.5 mg/mL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
      HostMouse
      SpecificityClone MAB423 (L2) is a mouse monoclonal antibody that detects EBV-LMP2A. It targets an epitope within 9 amino acids from the C-terminal region.
      IsotypeIgG1κ
      Species Reactivity
      • Human
      Species Reactivity NoteHuman.
      Antibody TypeMonoclonal Antibody
      Gene Symbol
      • LMP2
      Purification MethodProtein G purified
      UniProt Number
      Molecular Weight53.01 kDa calculated.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Flow Cytometry in T2 cells pulsed with LMP2 peptide (426-434).

      Flow Cytometry Analysis (FC): 1 µg of this antibody detected HLA-A2-EBV LMP2A in one million T2 cells pulsed with LMP2 peptide (426-434).
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsRecommended storage: +2°C to +8°C.
      Packaging Information
      Material Size100 μg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      MABF2302-100UG 04065267060316

      Documentation

      Anti-HLA-A02:01 EBV-LMP2A Antibody, clone MAB243 MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      Anti-HLA-A02:01 EBV-LMP2A Antibody, clone MAB243 Certificati d'Analisi

      TitoloNumero di lotto
      Anti-HLA-A02:01 EBV-LMP2A, clone MAB243 - 4167076 4167076
      Anti-HLA-A02:01 EBV-LMP2A, clone MAB243 - 4186029 4186029
      Anti-HLA-A02:01 EBV-LMP2A, clone MAB243 - 4209926 4209926
      Anti-HLA-A02:01 EBV-LMP2A, clone MAB243 - 4278875 4278875
      Anti-HLA-A02:01 EBV-LMP2A, clone MAB243 - 4301962 4301962
      Anti-HLA-A02:01 EBV-LMP2A, clone MAB243 - Q3845946 Q3845946